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Willin/FRMD6 is part of a family of proteins with a 4.1 ezrin-radixin-moesin (FERM)
domain. It has been identified as an upstream activator of the Hippo pathway
and, when aberrant in its expression, is associated with human diseases and
disorders. Even though Willin/FRMD6 was originally discovered in the rat sciatic nerve,
most studies have focused on its functional roles in cells outside of the nervous
system, where Willin/FRMD6 is involved in the formation of apical junctional cell-cell
complexes and in regulating cell migration. Here, we investigate the biochemical and
biophysical role of Willin/FRMD6 in neuronal cells, employing the commonly used
SH-SY5Y neuronal model cell system and combining biochemical measurements
with Elastic Resonator Interference Stress Micropscopy (ERISM). We present the first
direct evidence that Willin/FRMD6 expression influences both the cell mechanical
phenotype and neuronal differentiation. By investigating cells with increased and
decreased Willin/FRMD6 expression levels, we show that Willin/FRMD6 not only
affects proliferation and migration capacity of cells but also leads to changes in cell
morphology and an enhanced formation of neurite-like membrane extensions. These
changes were accompanied by alterations of biophysical parameters such as cell force,
the organization of actin stress fibers and the formation of focal adhesions. At the
biochemical level, changes in Willin/FRMD6 expression inversely affected the activity of
the extracellular signal-regulated kinases (ERK) pathway and downstream transcriptional
factor NeuroD1, which seems to prime SH-SY5Y cells for retinoic acid (RA)-induced
neuronal differentiation.
Keywords: Willin/FRMD6, neuronal differentiation, ERK1/2, cell mechanics, actin, focal adhesion, TAZ, cell
force measurement
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INTRODUCTION
Willin/FRMD6 is part of a family of proteins in which a 4.1 ezrin-
radixin-moesin (FERM) domain has been identified (Gunn-
Moore et al., 2005). Members of the FERM protein family have
been linked to a variety of signaling pathways and their aberrant
expression is associated with human diseases and disorders
(Moleirinho et al., 2013a; Gunn-Moore et al., 2016). Specifically,
Willin/FRMD6 is an upstream component of theHippo signaling
pathway that can regulate the activity of the transcriptional factor
YAP/TAZ to influence cell morphology and behavior (Angus
et al., 2012; Moleirinho et al., 2013b).
Willin/FRMD6 has been indirectly linked to the nervous
system, for example, it was first isolated from the rat sciatic
nerve (Gunn-Moore et al., 2005), where it controls the activity of
fibroblasts (Moleirinho et al., 2013c) and potentially influences
myelination (Fernando et al., 2016). Also, single nucleotide
polymorphisms associated with the frmd6 gene have been
associated with hippocampal atrophy and Alzheimer’s disease
in the Alzheimer’s Disease Neuroimaging Initiative (ADNI;
Hong et al., 2012; Shen et al., 2014; Nho et al., 2016).
Despite these findings, most studies to date have focused on
Willin/FRMD6 functional roles in cells outside of the nervous
system, where in addition to influencing the Hippo pathway,
Willin/FRMD6 is involved in forming apical junctional cell-cell
complexes through interaction with Par3, atypical protein kinase
C (aPKC) and Par6 (Ishiuchi and Takeichi, 2011). As well as these
links between Willin/FRMD6 and the cellular architecture, it is
now becoming apparent that other components of the Hippo
signaling pathway are linked to not only transducing but also
changing the mechanical properties of cells and so can influence
their surrounding physical environment (Totaro et al., 2018).
In this report, we sought to shed light on the biochemical
and biophysical role of Willin/FRMD6 in the commonly used
SH-SY5Y neuronal model cell system (Kovalevich and Langford,
2013). SH-SY5Y cells are a widely used neuroblastoma cell
line that is proliferative and can differentiate into neuronal-like
cells using chemical agents such as retinoic acid (RA; Encinas
et al., 2000). They exhibit Willin/FRMD6 expression levels
identical to primary mouse cortical neurons (Supplementary
Figure S1) and are thus well suited as a model for investigation
of Willin/FRMD6 in a neuronal setting. As well as looking
at the effect of Willin/FRMD6 on key components of these
cells, we used Elastic Resonator Interference Stress Microscopy
(ERISM; Kronenberg et al., 2017), to study the involvement of
Willin/FRMD6 in biophysical aspects of SH-SY5Y cells. ERISM
is a recently developed forcemapping tool that allows for imaging
of cell forces with high spatial resolution.
Combining ERISM with biochemical measurements, we
discovered that manipulating Willin/FRMD6 expression levels
in SH-SY5Y cells influences both biochemical and biophysical
effects. Reducing endogenous Willin/FRMD6 expression
resulted in a change in proliferation rate and cell morphology,
specifically an increase in fine membrane extensions, which in
turn rendered the cells more susceptible to differentiation
following RA stimulation. These cellular changes were
accompanied by changes in the forces that the cells
exerted onto their environment. Furthermore, changes in
Willin/FRMD6 expression resulted in alterations of the actin
cytoskeleton and the localization of TAZ; though notably these
events were controlled by activation of the extracellular signal-
regulated kinases (ERK) pathway. These combined biochemical
and physical measurements provide the first direct evidence
that Willin/FRMD6 has potential roles in the development of
neuronal-like cells and that these occur predominantly through
the ERK signal transduction pathway.
MATERIALS AND METHODS
Cell Culture
SH-SY5Y cells were obtained from ATCC (CRL-2266) and
cultured according to ATCC guidelines. The SH-SY5Y cell line
consists of a heterogeneous population that is predominantly
composed of N-type cells with a small fraction of S-type
cells. According to previous reports, N-type cells have faster
proliferation rates when compared to S-type cells (Bell et al.,
2013). All experiments in this study were performed on mixed
cultures within 20 cell doublings. For the generation of the
SH-SY5Y cells used in knockdown studies, lentiviral particles
containing shRNAs designed to silence Willin mRNA (shWillin:
19mer target sequences: 5’-ACAGAGCAGCAAGATACTA-3’)
or a scrambled RNA sequence (shScr) were produced in
HEK293T cells as previously described (Angus et al., 2012).
To generate SH-SY5Y cells overexpressing Willin (Willin) and
reference cells (Vector), retroviral particles were generated in
Phoenix A cells as previously described (Tilston-Lünel et al.,
2016). Antibiotic selection was maintained for 3 weeks of
post-viral transduction.
Western Blot Analysis
Lysates of cell monolayers were prepared using lysis buffer
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1.0% Triton X-
100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate
(SDS); all reagents purchased from Sigma–Aldrich), and lysate
protein concentrations measured by BCA assay. Protein samples
prepared with 20 µg of protein lysate and 5× loading buffer
(500 mM dithiothreitol, 250 mM Tris-HCl, pH 6.8, 50%
glycerol, 10% SDS, 0.25% bromophenol blue) were denatured
by heating at 95◦C for 5 min and separated by SDS-PAGE.
Proteins were then transferred in a liquid buffer (25 mM Tris
base, pH 8.3, 192 mM glycine, 20% (v/v) methanol) onto a
PVDF membrane (EMD Millipore) using a Bio-Rad blotting
module at 25 V for 90–120 min. Membranes were stained
with Ponceau S solution (Sigma–Aldrich) to verify effective
protein transfer, then washed with TBS-T (20 mM Tris base,
pH 7.6, 150 mM NaCl, 0.1% Tween-20). Membranes were
blocked in either 5% skimmed dried milk in TBS-T or 5%
BSA in TBS-T for 1 h at room temperature, before being
incubated with primary antibody diluted in blocking solution
overnight at 4◦C [FRMD6: Cell Signaling Technology, 14688,
1:100; Phospho-p44/42 MAPK: Cell Signaling Technology, 4370,
1:4,000; p44/42 MAPK (ERK1/2): Cell Signaling Technology,
9107, 1:2,000; NeuroD1: Santa Cruz Biotechnology, sc-1084,
1:100; Vinculin: Novus Biologicals, NBP2-41274, 1:500; β-actin:
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Sigma–Aldrich, A1978, 1:20,000; GAPDH: Sigma–Aldrich,
G8795, 1:20,000]. Membranes were then washed three times
with TBS-T for 10 min and incubated with horseradish
peroxidase (HRP)-conjugated secondary antibody diluted in
blocking solution for 1 h at room-temperature (Abcam,
ab6789, 1:10,000; Abcam, ab97051, 1:10,000; LI-COR, 925-32210,
1:25,000; LI-COR, 925-68071, 1:25,000). Membranes were
washed with TBS-T for 15 min three times, and protein bands
were detected by the addition of 0.75 ml Immobilon Western
Chemiluminescent HRP Substrate for 1 min. Protein bands
were visualized with the Fujifilm LAS-3000 imaging system and
analyzed using FIJI. Alternatively, membranes were incubated
with fluorescently labeled secondary antibodies (Li-Cor) and
bands detected using the Li-Cor Odyssey CLx (Li-Cor). Bands of
the protein of interest were quantified using GAPDH or β-actin
as a loading control.
qPCR Analysis
Quantitative PCR of the synthesized cDNA was conducted
using Brilliant II SYBRr Green QPCR Master Mix (Agilent)
or Brilliant III Ultra-Fast SYBRr Green QPCR Master Mix
(Agilent) according to the manufacturer’s protocol. qPCR
reactions were performed on a Roto-Gen Q Series (activation
of the polymerase at 95◦C for 600 s; denaturation at 95◦C for
30 s, 40 cycles; annealing and elongation at 60◦C for 60 s;
melt curves: 55–95◦C at 30 s per 0.5◦C) and analyzed using
Rotor-Gene Q Series Software. No template controls reactions
using nuclease-free water were run for every primer pair during
every run to evaluate the background signal. Relative changes
in gene expression were calculated according to the 2−∆∆CT
method. The sequences of the qPCR primers are described in
Supplementary Table S1.
Cell Migration Assay Using a Boyden
Chamber
A serum-free SH-SY5Y cell suspension (5× 105 cells) was added
to cell culture inserts with 8.0 µm pores (BD Biosciences, UK).
Growth media supplemented with 20% serum was added to the
lower chamber. The bottom side was stained with 0.3% crystal
violet (Sigma–Aldrich). The number of cells on the lower surface
of each chamber was counted from images acquired using a Zeiss
Axiovert 40CFL microscope.
ERISM Measurements
ERISM substrates with an apparent stiffness of 3 kPa were
fabricated as described previously (Kronenberg et al., 2017)
and four silicon chambers (surface area: 0.75 × 0.75 cm2;
Ibid) were applied. The substrate was incubated with a type I
collagen suspension (Collagen A, Biochrome) at pH 3.0–3.5 for
1 h at 37◦C and then washed with cell culture medium. The
different SH-SY5Y cell lines (shScr, shWillin, Vector, andWillin)
were investigated in different wells on the same ERISM chip.
Cells were seeded onto the ERISM substrate at 3,000 cells
per well and kept at 37◦C, 5% CO2 culture conditions in
complete growth media for 24 h to allow adhesion to complete.
ERISM measurements were performed and displacement maps
were computed as previously described in Kronenberg et al.
(2017). For the Fourier-filtered ERISM map, an FFT band-pass
filter with an upper cut-off frequency of 3.2 µm was applied
to the raw displacement maps using FIJI. For cell force
analysis, ‘‘indented volume’’ was calculated by numerically
integrating the displacement below −10 nm under each cell
(Kronenberg et al., 2017).
Cell Morphology
The area of cells was measured from phase-contrast images taken
24 h after seeding the cells on ERISM substrates. For this, the
outlines of the cells were drawn by hand using the FIJI software
package and the area of the marked region was calculated. Cell
elongation factors were calculated from the same images by
measuring the longest (l) and shortest (s) diameter of a cell and
calculating the elongation as (1 – s/l).
Cell membrane extension lengths were determined by hand
using the FIJI software package. All cells possessing at least one
extension with a length at least twice the cell body diameter were
classified as a neurite-like extension-bearing cell (‘‘pre-neurite’’;
Popovics et al., 2013). Results were expressed as the percentage of
fine extension bearing cells in the entire cell ensemble.
Immunostaining
For immunochemistry staining, cells were either fixed directly
on ERISM substrates or coverslips. Fixation was achieved with
4% paraformaldehyde (Alfa Aesar) in PBS at room temperature
for 20 min. Cells were washed twice with 0.05% Tween-20 in
PBS (Alfa Aesar), permeabilized with 0.1% Triton X-100 (Alfa
Aesar) in PBS for 3 min, washed twice again, and blocked
for 30 min with 1% BSA (Carl Roth) in PBS. Fixed cells
on ERISM chips were simultaneously incubated with primary
antibodies for vinculin (Merck Millipore, 90227, 1:250) and
TAZ (Sigma–Aldrich, HPA007415, 1:100) in blocking solution
for 60 min at RT, washed three times, incubated with the
secondary antibodies (Sigma–Aldrich, F0257, 1:32; Jackson
ImmunoResearch, 711-175-152, 1:400) and TRITC-conjugated
phalloidin (Merck Millipore, 90228, 1:500) in blocking solution
for 45 min at RT, washed three times, and stained with DAPI
(Merck Millipore, 90229, 1:1,000 in blocking solution for 3 min
at RT). Fixed cells on coverslips were incubated with a primary
antibody for neuroD1 (Santa Cruz Biotechnology, sc-1084,
1:50 in blocking solution, overnight at 4◦C), washed, incubated
with a secondary antibody (Jackson ImmunoResearch, 205-482-
176, 1:1,000 in PBS for 30 min at RT) and washed again. Antifade
Mountant with DAPI (Invitrogen; P36935) was used to visualize
cell nuclei.
Differentiation of SH-SY5Y Cells
SH-SY5Y cells were plated on the ERISM substrate or glass
coverslip and incubated for 24 h. Cells then underwent two gentle
washes of PBS to remove any excess serum leftover from the
growth media before the addition of SH-SY5Y differentiation
media [DMEM:F12, 1% FBS, 1% Penicillin/Streptomycin, 10µM
(RA, 10mM in EtOH)]. Fresh differentiationmedia was added to
the cells every 2 days for a period of 7 or 8 days. Differentiated
cells were defined as cells with neurites that were longer than
40 µm.
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RESULTS
Knock-Down of Willin/FRMD6 Affects
Proliferation, Migration, Morphology and
Force Exertion of SH-SY5Y Cells
We generated an SH-SY5Y cell line (shWillin) with a reduced
expression level of endogenous Willin/FRMD6 using a
short hairpin interference construct and a control cell line
(shScr) with a scrambled short hairpin interference construct.
Successful generation was confirmed by Western blotting
(mean relative Willin/FRMD6 expression ± SEM: shScr:
1.00 ± 0.02, n = 3; shWillin: 0.17 ± 0.02, n = 3; Student’s
t-test: p ≤ 0.001; Figure 1A) and qPCR analysis (mean relative
Willin/FRMD6 mRNA expression ± SEM: shScr: 1.00 ± 0.02,
n = 6; shWillin: 0.08 ± 0.01, n = 6; Student’s t-test: p ≤ 0.001;
Figure 1B).
A decrease in Willin/FRMD6 expression increased
proliferation (mean cell number after 8 days ± SEM: shScr:
22,600 ± 600, n = 9; shWillin: 46,700 ± 1,700, n = 9; Student’s
t-test: p ≤ 0.001) and migration capacity (mean number
of migrating cells ± SEM: shScr: 331 ± 9, n = 6; shWillin:
417 ± 8, n = 6; Student’s t-test: p ≤ 0.001; Figures 1C,D) of
SH-SY5Y cells.
To investigate if Willin/FRMD6 knockdown also led to
changes in cellular force exertion, shScr and shWillin cells
were seeded on ERISM substrates and investigated after letting
them firmly adhere to the substrate for 24 h. Figure 1E shows
phase contrast images of representative shScr and shWillin
cells as well as ERISM maps which show the deformation
of the mechanical activity of the cells caused to their soft
substrate. Taking the volume by which the cells indent into the
ERISM substrate as a proxy for the magnitude of the exerted
force, Willin/FRMD6 knockdown resulted in a significant
reduction of cell force [mean indented volume ± SEM: shScr:
(77 ± 5) µm3, n = 50; shWillin: (25 ± 3) µm3, n = 57;
Student’s t-test: p ≤ 0.001; Figures 1E,F]. Spatial Fourier-
filtering was used to filter out broad deformation features
from the ERISM displacement maps to resolve finer details
of the mechanical interactions of the cells with the substrate.
The Fourier-filtered ERISM displacement maps in Figure 1E
show substrate twisting at the periphery of both cells. We have
previously shown that twisting of ERISM substrates is caused
by contractile actomyosin forces that are transmitted to the
substrate by focal adhesion complexes (Kronenberg et al., 2017).
The number of focal adhesion contacts and the magnitude
of substrate twisting, and thus exerted force, was reduced for
shWillin cells, again indicating a reduction in cell force upon
Willin/FRMD6 knockdown.
As evident from Figure 1E and Supplementary Figure
S2, reduction in expression of Willin/FRMD6 also led to
morphological changes in shWillin cells, which manifested as an
increase in the number of small fine extensions (see discussion of
Figure 4 below), a decrease in cell area [mean cell area ± SEM:
shScr: (867± 63) µm2, n = 24; shWillin: (573± 41) µm2, n = 37;
Student’s t-test: p ≤ 0.001; Figure 1G] and an increase in cell
elongation (mean cell elongation ± SEM: shScr: 0.46 ± 0.05,
n = 20; shWillin: 0.66 ± 0.03, n = 37; Student’s t-test: p ≤ 0.001;
Figure 1H).
Knock-Down of Willin/FRMD6 Alters
Vinculin Expression, Focal Adhesion
Assembly, and Actin Cytoskeleton
Dynamics
To further investigate the effect of Willin/FRMD6 knockdown
on exertion and transmission of cell force, shScr and shWillin
cells were fixed on ERISM substrates and immunostained for
the focal adhesion protein vinculin, the cytoskeleton protein
actin and the mechanosensitive transcription co-activator TAZ
(Figure 2A).
In line with the observation from the Fourier-filtered ERISM
maps in Figure 1E, a decrease in Willin/FRMD6 expression
resulted in the formation of fewer (mean number of focal
adhesions per cell ± SEM: shScr: 30 ± 5, n = 24; shWillin:
16 ± 2, n = 37; Student’s t-test: p ≤ 0.01; Figures 2A,B) and
smaller [mean average area of focal adhesion in cell ± SEM:
shScr: (2.0 ± 0.2) µm2, n = 24; shWillin: (1.3 ± 0.1) µm2,
n = 37; Student’s t-test: p≤ 0.001; Figures 2A,C] focal adhesions.
The position of vinculin in the fluorescence images co-localized
with twisting in the Fourier-filtered ERISM maps, proving that
the cells exert contractile forces via focal adhesion complexes.
Western blotting showed a reduction in the overall vinculin
expression (mean relative vinculin expression ± SEM: shScr:
1.00 ± 0.02, n = 3; shWillin: 0.63 ± 0.02, n = 3; Student’s
t-test: p ≤ 0.001; Figure 2D). Also, shWillin cells showed
the impaired formation of actin stress fibers (Figure 2A)
and a reduction of the nuclear/cytosolic TAZ ratio (mean
nuclear/cytosolic TAZ ratio ± SEM: shScr: 1.7 ± 0.1, n = 20;
shWillin: 1.3 ± 0.1, n = 26; Student’s t-test: p ≤ 0.01; Figure 2E)
while the total TAZ expression was unchanged (Supplementary
Figure S3). Nuclear/cytosolic TAZ ratio roughly correlated
with the number of focal adhesions and the mechanical
activity for both shScr and shWillin cells (Figures 2F,G).
While YAP RNA expression is generally low in SH-SY5Y
cells, the amount of total YAP in Willin/FRMD6 knockdown
cells was significantly diminished when compared to control
cells (Supplementary Figure S3).
These data show that the knockdown of Willin/FRMD6 leads
to general suppression of the mechanical activity of SH-SY5Y
cells on various critical levels, as well as tomorphological changes
towards smaller but more elongated cells that form an increased
number of small cell extensions.
Willin/FRMD6 Overexpression Results in a
General Reversion of the Findings
Observed for Knock-Down Cells and
Activate the Mechanical Activity of
SH-SY5Y Cells
To investigate the effects of increased
Willin/FRMD6 concentration, SH-SY5Y cells (Willin)
overexpressing Willin/FRMD6 and reference cells (Vector)
were generated by retroviral transfection. Western blot (mean
relative Willin/FRMD6 expression ± SEM: Vector: 1.00 ± 0.06,
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FIGURE 1 | Knock-down of Willin/FRMD6 affects proliferation, migration, morphology, and force exertion of SH-SY5Y cells. (A) Quantitative Western blot analysis of
Willin/FRMD6 expression in control (shScr) and Willin/FRMD6 knock-down (shWillin) SH-SY5Y cells. Means were calculated from three independent experiments.
Error bars represent SEM. GAPDH serves as a loading control of the lysates. (B) qPCR analysis of Willin/FRMD6 mRNA expression in shScr and shWillin cells.
Means and SEM (error bars) were calculated from two independent experiments, each of which was conducted in triplicates. (C) Growth curve of shScr and shWillin
cells. Means (horizontal lines) and SEM (error bars) were calculated from three independent experiments, each of which was conducted in triplicates. (D) Assessment
of migration of shScr and shWillin cells in Boyden chambers after 24 h. Means (horizontal lines) and SEM (error bars) were calculated from two independent
experiments, each of which was conducted in triplicates. (E) Phase-contrast images (upper row), ERISM displacement maps (middle row), and Fourier-filtered
ERISM maps (lower row) of representative shScr (left column) and shWillin (right column) cell. Scale bars: 25 µm. Comparison of (F) volume by which cells indent into
the ERISM substrate, (G) cell area, and (H) cell elongation of shScr and shWillin cells. Each data point represents the measured value for one cell taken from four (F)
and two (G,H) independent experiments, respectively, lines indicate means, error bars SEM. Groups were compared using Student’s t-test; ***p ≤ 0.001.
n = 6; Willin: 2.40 ± 0.03, n = 6; Student’s t-test: p ≤ 0.001;
Figure 3A) and qPCR (mean relative Willin/FRMD6 mRNA
expression± SEM:Vector: 1.00± 0.04, n = 6;Willin: 3.09± 0.07,
n = 6; Student’s t-test: p≤ 0.001; Figure 3B) were used to confirm
successful Willin/FRMD6 overexpression.
An increase in Willin/FRMD6 led to a reversal of most
of the findings made for Willin/FRMD6 knock-down cells.
In detail, compared to Vector cells, Willin cells showed
decreased proliferation (mean cell number after 8 days ± SEM:
Vector: 25,100 ± 1,200, n = 9; Willin: 18,500 ± 2,400,
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FIGURE 2 | Knock-down of Willin/FRMD6 alters vinculin expression, focal adhesion assembly, and actin cytoskeleton dynamics. (A) Representative phase-contrast
images (upper row), immunostainings against F-actin (red), vinculin (green) and DNA (blue; middle row) and TAZ (lower row) of control (shScr) and Willin/FRMD6
knock-down (shWillin) SH-SY5Y cells. Scale bars: 30 µm. Comparison of (B) the number of focal adhesions per cell, (C) the mean area of a single focal adhesion,
and (E) the nuclear/cytosolic TAZ ratio in shScr and shWillin cells. Each data point in (B), (C) and (E) represents the measurement value for one cell taken from two
independent experiments. Lines indicate means, error bars SEM. (D) Quantitative Western blot analysis of vinculin expression in shScr and shWillin cells. Means
were calculated from three independent experiments. Error bars represent SEM. GAPDH serves as a loading control of the lysates. Correlation between the ratio of
nuclear to cytoplasmic TAZ concentration, (F) the number of focal adhesions, and (G) the volume by which cells indent into the ERISM substrate for shScr (green
dots) and shWillin (yellow dots) SH-SY5Y cells. Groups were compared using Student’s t-test; **p ≤ 0.01; ***p ≤ 0.001.
n = 9; Student’s t-test: p ≤ 0.001; Figure 3C) and migration
(mean number of migrating cells ± SEM: Vector: 313 ± 7,
n = 6; Willin: 263 ± 6, n = 6; Student’s t-test: p ≤
0.001; Figure 3D). However, no differences in vinculin
expression and actin arrangement were found (Figure 3E).
Furthermore, the observed increase in cell area [mean cell
area ± SEM: Vector: (747 ± 62) µm2, n = 28; Willin:
(802 ± 54) µm2, n = 37; Student’s t-test: p > 0.05;
Figure 3F] and decrease in cell elongation (mean cell elongation
factor ± SEM: Vector: 0.50 ± 0.05, n = 30; Willin: 0.43 ± 0.04,
n = 37; Student’s t-test: p > 0.05; Figure 3G) of Willin
cells compared to Vector cells were both not statistically
significant (Supplementary Figure S2). Nuclear/cytosolic TAZ
ratio (mean nuclear/cytosolic TAZ ratio ± SEM: Vector:
1.10 ± 0.02, n = 27; Willin: 1.24 ± 0.04, n = 29; Student’s
t-test: p ≤ 0.001; Figure 3H) and cell force [mean indented
volume ± SEM: Vector: (63 ± 8) µm3, n = 30; Willin:
(91 ± 7) µm3, n = 31; Student’s t-test: p ≤ 0.01; Figure 3I],
on the other hand, significantly increased in cells with higher
Willin/FRMD6 expression.
Knockdown of Willin/FRMD6 in SH-SY5Y
Cells Activates the ERK1/2 Pathway and
Elicits Differentiation Into a Neuronal
Phenotype by Activation of the
Transcriptional Factor NeuroD1
The changes in proliferation and morphology observed in the
Willin/FRMD6 knockdown SH-SY5Y cells were reminiscent
of ERK1/2-induced changes that have been observed in other
neuronal cell lines (Gunn-Moore and Tavaré, 1998). We,
therefore, explored whether basal ERK1/2 kinase activity was also
changed in response to modulation of Willin/FRMD6 protein
levels. Western blot analysis demonstrated that the knockdown
of Willin/FRMD6 led to an increase of the amount of
phosphorylated ERK1/2 compared to total ERK1/2 protein
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FIGURE 3 | Willin/FRMD6 over-expression results in a general reversal of the findings observed for knock-down cells and activate the mechanical activity of
SH-SY5Y cells. (A) Quantitative Western blot analysis of Willin/FRMD6 for control (Vector) and Willin/FRMD6 overexpressing (Willin) SH-SY5Y cells. Means and SEM
(error bars) were calculated from two independent experiments, each of which was conducted in triplicates. β-actin serves as a loading control of the lysates. (B)
qPCR analysis of Willin/FRMD6 expression in Vector and Willin cells. Means and SEM (error bars) were calculated from two independent experiments, each of which
was conducted in triplicates. (C) Growth curve of Vector and Willin cells. Means and SEM (error bars) were calculated from three independent experiments, each of
which was conducted in triplicates. (D) Assessment of migration of shScr and shWillin cells in Boyden chambers after 24 h. Means (horizontal lines) and SEM (error
bars) were calculated from two independent experiments, each of which was conducted in triplicates. (E) Representative phase-contrast images (upper row),
immunostainings against F-actin (red), vinculin (green) and DNA (blue; middle row), and TAZ (lower row) of Vector and Willin SH-SY5Y cells. Scale bars: 30 µm.
Comparison of (F) cell area, (G) cell elongation, (H) nuclear/cytosolic TAZ ratio, and (I) volume by which cells indent into the ERISM substrate for Vector and Willin
cells. Each data point represents the value measured for one cell. Lines indicate means, error bars SEM. Groups were compared using Student’s t-test; ns:
p > 0.05; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
levels (mean relative phosphorylated ERK1/2 level ± SEM:
shScr: 1.0 ± 0.1, n = 3; shWillin: 2.8 ± 0.3, n = 3;
Student’s t-test: p ≤ 0.001; Figure 4A), while overexpression
of Willin/FRMD6 had the opposite effect (mean relative
phosphorylated ERK1/2 level ± SEM: Vector: 1.00 ± 0.02, n = 3;
Willin: 0.66± 0.05, n = 3; Student’s t-test: p≤ 0.001; Figure 4B).
An increase in ERK1/2 phosphorylation was also observed in
wild type SH-SY5Y cells that were treated with 10 µM RA,
which is known to induce neuronal differentiation (mean relative
phosphorylated ERK1/2 level± SEM: DMSO: 1.00± 0.03, n = 3;
RA: 2.46± 0.08, n = 3; Student’s t-test: p ≤ 0.001; Figure 4C).
We next examined whether the morphological and
biochemical effects observed in the Willin/FRMD6 knockdown
SH-SY5Y cells were dependent on active ERK signaling. For
this, we used U0126, a highly selective MEK inhibitor that
prevents the activation of ERK1/2 (Favata et al., 1998). Inhibition
of MEK by U0126 treatment (10 µM) was indeed effective
at blocking the activation of ERK1/2 caused by the decrease
of Willin/FRMD6 expression in shWillin cells (mean relative
phosphorylated ERK1/2 level ± SEM: DMSO: 1.00 ± 0.03,
n = 3; U0126: 0.13 ± 0.01, n = 3; Student’s t-test: p ≤ 0.001;
Figure 4D). Blocking ERK1/2 activation via U0126-mediated
MEK inhibition reduced the formation of neurite-like extensions
in Willin/FRMD6 knock-down cells down to the level of
control cells (mean percentage of cells with neurite-like
extensions ± SEM: shScr-DMSO: 1.3% ± 0.3%, n = 6; shWillin-
U0136: 2.3% ± 0.8%, n = 6; shWillin-DMSO: 13.3% ± 0.8%,
n = 6; Student’s t-test: p(shScrDMOS-shWillinU0126) > 0.05,
p(shWillinU0126-shWillinDMSO) ≤ 0.001; Figure 4E and
Supplementary Figure S4) and returned the cell force
of Willin/FRMD6 knock-down cells back to the level of
control cells [mean indented volume ± SEM: shScr-DMSO:
(120 ± 12) µm3, n = 34; shWillin-U0126: (95 ± 8) µm3,
n = 54; shWillin-DMSO: (75 ± 7) µm3, n = 44; Student’s
t-test: p(shScrDMSO-shWillinU0126) > 0.05, p(shWillinDMSO-
shWillinU0126) ≤ 0.05; Figure 4F]. Blocking ERK1/2 activation
with U0126 also stalled RA-induced differentiation of control
and Willin/FRMD6 knocked down cells, which indicates that
U0126 treatment directly affects differentiation of SH-SY5Y cells
(mean percentage of differentiated cells after 4 days ± SEM:
shScr-DMSO: 8.6% ± 1.5%, n = 6; shScr-U0136: 5.1 ± 0.2%,
n = 6; shWillin-DMSO: 19.1% ± 1.5%, n = 6; shWillin-
U0136: 4.6% ± 0.5%, n = 6; Student’s t-test: p(shScrDMSO-
shScrU0126) ≤ 0.05, p(shWillinDMSO-shWillinU0126) ≤
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0.001; Figure 4G). These findings suggest that the reduction
of Willin/FRMD6 protein levels in SH-SY5Y cells leads to
the activation of known signaling transduction pathways and
promotes neuronal differentiation.
We looked at NeuroD1 levels to test this hypothesis.
NeuroD1 is a transcriptional factor activated downstream of
ERK1/2 (Petersen et al., 2002). It is known to be upregulated
upon RA-induced differentiation of SH-SY5Y cells and is
thus associated with control of neurite outgrowth (López-
Carballo et al., 2002). NeuroD1 has also been reported to
translocate to the nucleus after its phosphorylation by ERK2.
For this reason, we explored whether the knockdown of
Willin/FRMD6 and associated activation of ERK1/2 was able to
phenocopy the RA-mediated increase of NeuroD1 expression.
An elevation in NeuroD1 expression was observed in the
Willin/FRMD6 knockdown cells using both Western blot (mean
relative NeuroD1 expression ± SEM: shScr: 1.0 ± 0.1, n = 6;
shWillin: 1.7 ± 0.2, n = 6; Student’s t-test: p ≤ 0.001;
Figure 4H) and qPCR analysis (mean relative NeuroD1 mRNA
expression ± SEM: shScr: 1.00 ± 0.02, n = 6; shWillin:
16.00 ± 0.02, n = 6; Student’s t-test: p ≤ 0.001; Figure 4I).
Furthermore, knockdown of Willin/FRMD6 led to a change
in cellular localization of NeuroD1, specifically an increased
presence of NeuroD1 in the cell nucleus (Figure 4J).
Next, shScr and shWillin cells were exposed to RA over 7 days
to induce neuronal differentiation (Supplementary Figure S5).
Figure 4K shows that the proportion of cells with growing
neurite-like extensions was approximately doubled in cells with
low Willin/FRMD6 expression after 4 and 7 days (percentage
of cells with neurite-like extensions after 7 days ± SEM:
shScr: 30% ± 1%, n = 6; shWillin: 49% ± 4%, n = 6; Student’s
t-test: p ≤ 0.001), which is in-line with the hypothesis that
increased activation of ERK1/2 in these cells make them
more susceptible for RA-induced neuronal differentiation
(Figure 4A). Inhibition of ERK1/2 blocked the RA-induced
neurite elongation in both cell types (Figure 4G), which
suggested that activation of ERK1/2 is the main mechanism
regulating neuronal differentiation. The enhanced neurite
growth was specific to a reduction of Willin/FRMD6 expression;
increasing Willin/FRMD6 expression did not affect RA
induced differentiation of SH-SY5Y cells (data not shown).
Also, when followed over 1 week, the mechanical activity
of Willin/FRMD6 knockdown cells converged towards
the mechanical activity of control cells for which neuronal
differentiation was induced by RA treatment [mean indented
volume after 8 days ± SEM: shScr: (74 ± 11) µm3, n = 18;
shScr-RA: (16 ± 4) µm3, n = 12; shWillin: (29 ± 5) µm3,
n = 11; Student’s t-test: p(shScr-shScrRA) ≤ 0.001, p(shScrRA-
shWillin) > 0.05; Figure 4L]. This shows that knockdown
of Willin/FRMD6 phenocopies the mechanical activity of
RA-induced neuronal differentiation.
DISCUSSION
The FERM domain-containing protein Willin/FRMD6 has
previously been shown to be an upstream activator of the
Hippo signaling pathway in a variety of different cell types
(Moleirinho et al., 2013a; Gunn-Moore et al., 2016). Even though
Willin/FRMD6 was originally discovered in the rat sciatic nerve
and subsequently has been shown to affect peripheral neuronal
formation and function (Moleirinho et al., 2013b; Fernando et al.,
2016), most studies have focused on its functional roles in cells
outside of the nervous system.
Here we showed that the neuroblastoma cell line SH-
SY5Y, which is a widely used neuronal model cell system,
expresses the Willin/FRMD6 protein at a level comparable to
primary mouse cortical neurons. Our data suggest that the
Willin/FRMD6 expression level influences cellular, biophysical,
and biochemical changes in SH-SY5Y cells. Specifically, reducing
the endogenous levels of Willin/FRMD6 led to an increase in
the proliferation and migration capacity and to pronounced
changes in the morphology of SH-SY5Y cells, such as cell
elongation and the production of fine extensions. Links between
Willin/FRMD6 and cell proliferation (Moleirinho et al., 2013c),
cell migration (Moleirinho et al., 2013c; Wang et al., 2019) or
cell morphology have been noted for other cell types before
Angus et al. (2012), Moleirinho et al. (2013c) and Gunn-Moore
et al. (2016). In all the reported cases, the observed changes
were attributed to the function of Willin/FRMD6 as an upstream
activator of the Hippo signaling pathway.
On the cell mechanical level, knocking down
Willin/FRMD6 expression in SH-SY5Y cells resulted in the
impaired organization of actin stress fibers; a reduction in
expression levels of vinculin and thus the formation of fewer
and smaller focal adhesions; a change in the localization of TAZ;
and reduction of the force the cells exerted on their substrate.
Mechanistically, it is conceivable that either the exclusion of the
transcription cofactor TAZ from the nucleus could result in the
transcriptional regulation of the cytoskeleton and focal adhesion,
or that reduced formation of focal adhesions regulates the
cytoskeleton which in turn regulates TAZ localization (Totaro
et al., 2018). The mechanism by which Willin/FRMD6 impacts
the mechanical phenotype of SH-SY5Y cells still needs to be
further examined. The FERM protein domain is generally
involved in localizing proteins, especially cytoskeletal-associated
proteins, to the plasma membrane (Chishti et al., 1998). It
was previously shown that Willin/FRMD6 co-localizes with
actin at the plasma membrane (Gunn-Moore et al., 2005), and
Willin/FRMD6 was previously reported to modulate cellular
F-actin organization in other cell types (Gunn-Moore et al.,
2016). In epithelial cells, Willin/FRMD6 localizes at apical
junctional complexes, where it regulates contractility of the
circumferential actomyosin cables via recruitment of aPKC
that in turn mediates phosphorylation of ROCK (Ishiuchi and
Takeichi, 2011). Willin/FRMD6 may have a similar role in focal
adhesion complexes of SH-SY5Y cells.
Our data show at the biochemical level, that the reduction of
endogenous Willin/FRMD6 protein level leads to the activation
of the ERK1/2 signaling transduction pathway with a correlative
increase in expression and change in cellular location of
the transcriptional factor NeuroD1. This seems to prime
SH-SY5Y cells for RA-induced neuronal differentiation. When
kept in culture over an extended period, SH-SY5Y cells with
reduced Willin/FRMD6 expression phenocopied RA-induced
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 September 2020 | Volume 14 | Article 552213
Kronenberg et al. Willin/FRMD6 Influences Mammalian Neuronal Differentiation
FIGURE 4 | Knockdown of Willin/FRMD6 in SH-SY5Y cells activates the ERK1/2 pathway and elicits differentiation into a neuronal phenotype by activation of the
transcriptional factor NeuroD1. Quantitative Western blot analysis of the levels of pERK1/2 relative to ERK1/2 (A) in control (shScr) and Willin/FRMD6 knock-down
(shWillin) SH-SY5Y cells, (B) in control (Vector) and Willin/FRMD6 overexpressing (Willin) SH-SY5Y cells, (C) in SH-SY5Y wild type cells treated with either DMSO or
retinoic acid (RA) and (D) in SH-SY5Y wild type cells treated with either DMSO or U0126. Means in (A) to (D) were calculated from three technical repeats. Error bars
represent SEM. Comparison of (E) percentage of fine extension-bearing cells and (F) volume by which cells deform the ERISM substrate (each data point represents
the value measured for one cell) for shScr cells treated with DMSO and shWillin cells treated with either DMSO or U0126 for 24 h. In (E) means were calculated from
two independent experiments conducted in triplicate. In (F) each data point represents the value measured for one cell. Lines indicate means, error bars SEM. (G)
Percentage of differentiating shScr and shWillin cells quantified from bright-field images of cells treated with 10 µM RA along with either DMSO or 10 µM U0126 for
4 days. Means and SEM (error bars) were calculated from two independent experiments, each of which was conducted in triplicates. Quantification of the levels of
NeuroD1 in shScr and shWillin cells from (H) Western blot analysis and (I) qPCR analysis. Means in (H) and (I) were calculated from two independent experiments
conducted in triplicate. Error bars represent SEM. (J) Immunofluorescent imaging of shScr (upper row) and shWillin (lower row) cells for NeuroD1 (left column) and
DNA (right column). Scale bars: 40 µm. (K) Quantification of extension bearing cells from bright-field images for shScr cells treated with 10 µM RA for 1, 4, and
7 days. Means and SEM (error bars) were calculated from two independent experiments, each of which was conducted in triplicates. (L) Development of the volume
by which cells indent into the ERISM substrate over 1 week during RA-initiated (10 µM) neuronal differentiation of shScr cells. Data points represent means
measured for ni individual cells; shaded areas represent SEM (Day 1: nshScr = 16, nshScrRA = 31, nshWillin = 22; Day 3: nshScr = 21, nshScrRA = 17, nshWillin = 14; Day 6:
nshScr = 12, nshScrRA = 16, nshWillin = 19; Day 8: nshScr = 18, nshScrRA = 12, nshWillin = 11). Groups were compared using Student’s t-test; ns: p > 0.05; *p ≤ 0.05;
**p ≤ 0.01; ***p ≤ 0.001.
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neuronal differentiation and showed similar levels of cell forces.
The observed changes in morphology and force exertion of
Willin/FRMD6 knockdown cells were suppressed in the presence
of the specific ERK1/2 inhibitor U0126, which suggests that the
cross-talk occurs upstream of the kinase, probably at the Ras/Raf
level as previously proposed (Romano et al., 2014). Our findings
are consistent with earlier reports showing that components
of the Hippo signaling pathway are linked to the ERK
pathway (Zhang et al., 2009; Reddy and Irvine, 2013; Romano
et al., 2014). Activation of ERK signaling and consequential
enhancement of induced neuronal differentiation has also
been reported upon the downregulation of the ERK-inhibitor
Spry4 in PC12 cells (Alsina et al., 2012) and upon increased
interaction with the neural cell adhesion molecule NCAM in
SH-SY5Y cells (Seidenfaden et al., 2006). Contrary to our
observation that activation of ERK inWillin/FRMD6 knockdown
cells resulted in reduced cell force exertion, ERK has been
reported to trigger cell contractility in a non-neuronal cell type
(Hino et al., 2020).
We also found that an increase of
Willin/FRMD6 concentration, on the other hand, triggered the
opposite cellular, morphological, mechanical, and biochemical
changes. However, the changes in phenotype observed for
knock-down cells were more pronounced than the reversed
effect seen in overexpressing cells.
While all observations suggest that
Willin/FMRD6 knockdown promotes differentiation of
SH-SY5Y cells, the functional relationship between the observed
phenomena and the potential involvement of the Hippo pathway
will still have to be investigated in the future. We show that
Willin/FRMD6 affects the nucleocytoplasmic shuttling of TAZ in
SH-SY5Y cells, even though the nuclear/cytoplasmic TAZ ratio
in Willin/FMRD6 knockdown cells was only reduced by 25%
compared to control cells. Neuronal differentiation of SH-SY5Y
cells in conjunction with cytoplasmic retention of TAZ as a result
of activation of Hippo signaling by the cadherin FAT1 has been
reported previously (Ahmed et al., 2015). It is conceivable that
Willin/FMRD6, which has been reported to play a role in cell-cell
contacts (Ishiuchi and Takeichi, 2011), has a similar function.
While total TAZ expression in SH-SY5Y cells was not affected
by Willin/FRMD6 knockdown, the observed reduction of the
already low total YAP expression in Willin/FRMD6 knockout
cells might support the assumption that Hippo signaling
could be interrupted by Willin/FRMD6 knockdown and that
alternative pathways might be involved. Downregulation of
YAP protein expression upon upregulation of Neurog2 (a
member of the same subgroup of bHLH transcription factors
for neurogenesis like NeuroD1) has been reported in mouse
retinal progenitor cells, and it was proposed that mutual
inhibition between proneural bHLH proteins and YAP is an
important regulator of proliferation and cell cycle exit during
mammalian neurogenesis (Zhang et al., 2012). By contrast, our
data show that Willin/FRMD6 knockdown not only promotes
neuronal differentiation of SH-SY5Y cells but also results in
increased proliferation.
Future work will also have to test whether the link
between Willin/FRMD6 and ERK1/2-activated differentiation
also occurs in primary neuronal cells. However, the
circumstantial evidence that Willin/FRMD6—like other
upstream components of the Hippo pathway—may be linked to
neurodegenerative diseases, leads to the intriguing hypothesis
that Willin/FRMD6 may play a role in the pathogenesis of these
diseases. Indeed, Willin/FRMD6 expression has been reported
to be down-regulated in Alzheimer’s disease models (Castillo
et al., 2017). Our work, therefore, opens the door for future
studies on how Willin/FRMD6 may not only influence neuronal
differentiation but may also play a role in neurodegeneration.
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